Research shows that automated breast ultrasound (ABUS) is a strong companion to traditional mammography, particularly for patients with dense breast tissue. The comprehensive scan provides a better interpretation than traditional mammography, enabling radiologists to catch cancers that might not otherwise be visible.

What is ABUS?



The global flat panel display market is predicted to reach $177.3 million by 2027, according to a new report titled “Flat Panel Display Market: Global Industry Analysis & Opportunity Assessment 2017-2027” from Future Market Insights. The market is anticipated to grow from $115.3 million in 2017 to $177.3 million by 2027, expanding at a compound annual growth rate (CAGR) of 4.4 percent in terms of revenue during the forecast period. According to the report, the increasing demand for higher resolution and larger display for mobile phones is boosting revenue growth of the global flat panel display market.



The market for mobile C-arm technology has been steady for the last several years, according to Jamie Dildy, BS, R.T. (R), clinical analyst for MD Buyline. The number of interventional procedures has been on the rise, and mobile C-arms provide a flexible, cost-effective option for image guidance during procedures across the hospital.


The Healthcare Information and Management Systems Society (HIMSS18) Conference and Exhibition was held last month in Vegas, and brought together nearly 44,000 members of the health IT community.


No technology concept is going to be more discussed, dissected or debated in healthcare this year than artificial intelligence (AI). In the world of radiology and imaging, AI has the potential to dramatically impact productivity, precision and outcomes. In fact, one of the most prominent use cases for AI applications in healthcare may be in imaging. However, several factors will impact the mainstream adoption of AI in 2018.



In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung cancer earlier, which can reduce mortality up to 20 percent.1 While the technology has proven effective, numerous research efforts have explored use of another up-and-coming technology — artificial intelligence (AI). This technology may further improve nodule detection, classification and sizing, while also reducing false-positive rates.



After a year of mixed fortunes, the global ultrasound market is set for a strong year in 2018. The three major geographic markets of Europe, the Middle East and Africa (EMEA), America and Asia are all forecast to grow faster than in 2017, driving a global growth rate of 5.1 percent, notably higher than the 3.2 percent growth seen last year. The main regional growth trends are discussed below.

U.S.: Uncertainty Eases Over Obamacare Repeal


The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT) systems from Siemens Healthineers. These additions to the company’s go. CT platform expand its concept of patient-centric mobile workflow, which is controlled via tablet and remote, into advanced clinical fields and applications such as cardiology, CT-guided intervention and dual energy CT.

Carestream Health is taking orders for its new Carestream DRX-Revolution Nano Mobile X-ray System in the United States. The company will be issuing budgetary quotes for healthcare providers in European Union countries as it completes the CE marking requirements. Carestream also has applied for a Health Canada License.

Subscribe Now